251 related articles for article (PubMed ID: 33420522)
41. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
[TBL] [Abstract][Full Text] [Related]
42. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
43. Role of carcinoembryonic antigen as a marker for colorectal liver metastases.
Jones C; Badger SA; Epanomeratikis E; McKie LD; Diamond T; Taylor MA
Br J Biomed Sci; 2013; 70(2):47-50. PubMed ID: 23888604
[TBL] [Abstract][Full Text] [Related]
44. Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.
Sasaki A; Kawano K; Inomata M; Shibata K; Matsumoto T; Kitano S
Hepatogastroenterology; 2005; 52(66):1814-9. PubMed ID: 16334783
[TBL] [Abstract][Full Text] [Related]
45. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.
Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
[TBL] [Abstract][Full Text] [Related]
46. Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer.
Kamada T; Ohdaira H; Takahashi J; Aida T; Nakashima K; Ito E; Hata T; Yoshida M; Eto K; Suzuki Y
Sci Rep; 2024 Feb; 14(1):4192. PubMed ID: 38378762
[TBL] [Abstract][Full Text] [Related]
47. Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
Wang YY; Liu ZZ; Xu D; Liu M; Wang K; Xing BC
Ann Surg Oncol; 2019 Oct; 26(11):3682-3692. PubMed ID: 31264117
[TBL] [Abstract][Full Text] [Related]
48. Is frequent measurement of tumor markers beneficial for postoperative surveillance of colorectal cancer?
Yokota M; Morikawa A; Matsuoka H; Muto J; Hashida K; Nagahisa Y; Masui T; Okabe M; Kitagawa H; Kawamoto K
Int J Colorectal Dis; 2023 Mar; 38(1):75. PubMed ID: 36947196
[TBL] [Abstract][Full Text] [Related]
49. Meta-analysis of the prognostic value of serum carcinoembryonic antigen in patients with colorectal cancer liver metastases after hepatectomy.
Yuan C; Zeng L; Duan H; Suksatit B
Eur J Cancer Prev; 2024 Jul; 33(4):334-346. PubMed ID: 37997904
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of preoperative carcinoembryonic antigen and D-dimer concentrations in patients undergoing curative resection for colorectal cancer.
Ojima Y; Harano M; Sumitani D; Yoshimitsu M; Okajima M
Surg Today; 2021 Jul; 51(7):1108-1117. PubMed ID: 33386463
[TBL] [Abstract][Full Text] [Related]
51. The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.
Okamura R; Hasegawa S; Hida K; Hoshino N; Kawada K; Sugihara K; Sakai Y;
Int J Clin Oncol; 2017 Feb; 22(1):96-101. PubMed ID: 27503134
[TBL] [Abstract][Full Text] [Related]
52. Serum Matrix Metalloproteinase-8 and Myeloperoxidase Predict Survival after Resection of Colorectal Liver Metastases.
Reijonen P; Peltonen R; Tervahartiala T; Sorsa T; Isoniemi H
Oncology; 2021; 99(12):766-779. PubMed ID: 34571507
[TBL] [Abstract][Full Text] [Related]
53. Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases.
Akiyama T; Miyamoto Y; Imai K; Yamashita Y; Nomoto D; Daitoku N; Sakamoto Y; Kiyozumi Y; Tokunaga R; Eto K; Harada K; Hiyoshi Y; Iwatsuki M; Nagai Y; Iwagami S; Baba Y; Yoshida N; Baba H
Ann Surg Oncol; 2020 Sep; 27(9):3534-3541. PubMed ID: 32648180
[TBL] [Abstract][Full Text] [Related]
54. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
[TBL] [Abstract][Full Text] [Related]
55. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K
Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715
[TBL] [Abstract][Full Text] [Related]
56. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
[TBL] [Abstract][Full Text] [Related]
57. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
[TBL] [Abstract][Full Text] [Related]
58. Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
Uratani R; Toiyama Y; Shimura T; Mori K; Fujikawa H; Hiro J; Ohi M; Inoue Y; Tanaka K; Araki T; Mohri Y; Kusunoki M
Anticancer Res; 2015 Oct; 35(10):5639-48. PubMed ID: 26408737
[TBL] [Abstract][Full Text] [Related]
59. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
[TBL] [Abstract][Full Text] [Related]
60. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
Qian X; Wang H; Ren Z; Jin F; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
